NCT07010913

Brief Summary

Participant Information Sheet Dear Participant, Investigators would like to invite participants to participate in a research study and explain what it involves. Please take a few moments to read the following information carefully. If you have any questions, feel free to ask us at any time. What is this study about? This study aims to understand how coronary angiography (a heart procedure you've recently had) may affect erectile function over time. Investigators are especially interested in whether the degree of blockage in participants' heart vessels and how well participants were treated during the procedure affect erectile health. What will participants be asked to do? If participants agree to take part: Investigators will ask participants to answer a short questionnaire with five questions about their erectile function. This will happen once while participants recover in the hospital and again 6 months later. Each question is rated on a simple scale from 0 to 5. Investigators will also collect some medical information, such as your age, weight, height, blood test results, details about your heart condition, other health problems, and the medications participants are taking. All information will be kept confidential and used only for scientific purposes. Participants' identities will not be revealed in any part of the study. Do participants have to take part? No. Participation is completely voluntary. Participants can choose not to take part, and you can also stop at any time without giving a reason. Participants' decisions will not affect their medical care in any way. Will there be any extra tests or costs? No. This study does not involve extra tests beyond regular medical care, such as blood tests or heart monitoring, and participation is free. How long will the study last? The study will last approximately one year. Once it's completed, participants are welcome to ask for the results from our institution. Who is conducting the study? The study is being conducted by: Assist Prof Dr. Timucin Sipal (Urology Department) Assist Prof Dr. Caglar Alp (Cardiology Department) You can contact them anytime using the phone number we have provided. What happens next? If participants are happy to participate, please sign the attached consent form. Sincerely, The Research Team

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

May 30, 2025

Last Update Submit

June 10, 2025

Conditions

Keywords

syntax scoreresidual syntax scoreerectile disfunction

Outcome Measures

Primary Outcomes (1)

  • Erectile functioning changes following percutaneous coronary intervention from baseline through 6 months

    Participants' answers will decrease or increase from the baseline score of 0 to 25 on the IIEF questionnaires following percutaneous coronary intervention after a heart attack.

    from February 2025 to September 2025

Study Arms (2)

Residual Syntax score more than 20%

Residual Syntax score less than and equal 20%

Eligibility Criteria

Age20 Years - 70 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale erectile disfunction study
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Male participants who have a heart attack and undergo percutaneous coronary intervention in our institutions and survive the event.

You may qualify if:

  • Having a First heart attack

You may not qualify if:

  • History of previous coronary intervention
  • Neurological condition
  • Previous pelvic surgery
  • Aged less than 20 and more than 70 years
  • Having an additional heart attack during the follow-up period
  • Excluding from the study
  • Having no sexual life

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

kirikkale Un'versity medical faculty

Kırıkkale, 71500, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Erectile Dysfunction

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant Professor/ Lecturer

Study Record Dates

First Submitted

May 30, 2025

First Posted

June 8, 2025

Study Start

February 14, 2025

Primary Completion

September 15, 2025

Study Completion

October 1, 2025

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
approximately at the end of August 2025

Locations